Portugal vs Sierra Leone: Access to anti-retroviral drugs, male
Portugal
82.0%
in 2017
Sierra Leone
82.0%
in 2024
Portugal rank
42nd
Sierra Leone rank
42nd
Access to anti-retroviral drugs, male over time
- Portugal
- Sierra Leone
How they compare
Portugal currently reports 82.0% against 82.0% in Sierra Leone, a difference of 0.0%.
Across all 18 years both countries report, Portugal has been ahead every year.
Portugal ranks 42nd and Sierra Leone ranks 42nd of 141 countries.
Portugal has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Portugal | Sierra Leone | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 30.8% | 1.5% | 29.3% | Portugal |
| 2010s | 63.9% | 13.2% | 50.6% | Portugal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Portugal or Sierra Leone?
- Portugal, at 82.0% against 82.0% in Sierra Leone as of 2017.
- What is the difference in access to anti-retroviral drugs, male between Portugal and Sierra Leone?
- 0.0%, with Portugal ahead.
- How many years of comparable data are there for Portugal and Sierra Leone?
- 18 years are reported by both, from 2000 to 2017.
- How do Portugal and Sierra Leone rank globally for access to anti-retroviral drugs, male?
- Portugal ranks 42nd and Sierra Leone ranks 42nd of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.